Radio- and chemotherapy for oesophageal cancers;Radio- et chimiotherapie des cancers de l'oesophage

Revue du Praticien

Volumn 49, Issue 11, 1999, Pages 1186-1191

  Tiret, Emmanuel ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; FLUOROURACIL; VINBLASTINE; VINDESINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; REVIEW; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CARCINOMA; CLINICAL TRIAL; ESOPHAGUS TUMOR; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0033151673     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Müller JM, Erasmi H, Stelzner M Zieren U, Pichlmaier H. surgical therapy of œsophageal carcinoma. Br J Surg 1990 ; 77 : 845-57.
2. Earlam R, Cunha-Melo JR. Œsophageal squamous cell carcinoma:a critical review of surgery. Br J Surg 1980 ; 67 : 380-90.
3. Herskovic A, Martz K, Al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the œsophagus. N Engl J Med 1992 ; 326 : 1593-8.
4. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with œsophageal cancer:an intergroup study.J Clin Oncol 1997 ; 15 : 277-84.
5. Launois B, Delarue D, Campion JP, Kerbaol M. Preoperative radiotherapy for carcinoma of the œsophagus. Surg Gyn Obstet 1981 ; 153 : 690-2.
6. Gignoux M, Roussel A, Paillot B et al. The value of preoperative radiotherapy in œsophageal cancer/ results of a study of the EORTC.World J Surg 1987 ; 11 : 426-32.
7. Wang M, Gu XZ, Yin WB, Huang G, Wang LJ, Zhang DW. Randomised clinical trial of the combination of preoperative irradiation and surgery in the treatment of oesophageal carcinoma: report on 206 patients. Int J Radat Oncol Biol Phys 1989 ; 16 : 325-7.
8. Nygaard K, Hagen S, Hansen H et al. Preoperative radiotherapy prolongs survival in operable œsophageal carcinoma: a randomised multicenter study of preoperative radiotherapy and chemotherapy.The second scandinavian trial in œsophageal cancer.World J Surg 1992 ; 16 : 1104-10.
9. French University Association for surgical research : Tenière P, Hay JM, Fingherut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower œsophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991 ; 173 : 123-30.
10. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomised clinical trial preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the œsophagus. J Thorac Cardiovasc Surg 1988 ; 96 : 242-8.
11. Schlag PM. Randomised trial of preoperative chemotherapy for squamous cell cancer of the œsophagus. The Chirurgische Arbeitgemeinschaft Fuer Onkologie der Deutschen gesellschaft Fuer Chirurgie Study Group.Arch Sirg 1992 ; 127 : 1446-50.
12. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the œsophagus:a prospective randomised trial. J Thorac Cardiovasc Surg 1997 ; 114 : 210-7.
13. Kelsen DP, Ginsberg R, Pajak TF et al. Chemotherapy followed by surgery compared with surgery alone for localised œsophageal cancer. N Engl J Med 1998 ; 339 : 1979-84.
14. Kok TC, von Lanschot J, Siersema PD, von Overhagen H, Talanus HV. Neoadjuvant chemotherapy in operable squamous cell cancer: final report of a phase III multicenter randomised controlled trial. Proc Am Soc Clin Oncol 1997 ; 16 (abstract) : 277 a.
15. Pouliquen X, Levard H, Hay JM et al. 5-fluorouracil and cispiatin therapy after palliative surgical resection of squamous cell carcinoma of the œsophagus: a multicenter randomised trial. Ann Surg 1996 ; 223 : 127-33.
16. Ando N, Iizuka T, Kakegawa T et al. A randomised trial of surgery with and without chemotherapy for localised squamous carcinoma of the thoracic œsophagus: the Japan clinical oncology group study. J Thorac Cardiovasc Surg 1997 ; 114 : 205-9.
17. Apinop C, Puttisak P Preecha N.A prospective study of combined therapy inœsophageal cancer. Hepatogastroenterol 1994 ; 41 : 391-3.
18. Urba S, Orringer M, Turrisi A, Whyte R, Lannettoni M, Forastiere A. A randomised trial comparing surgery to preoperative concomitant chemoradiation plus surgery in patients with resectable œsophageal cancer. Proc Am Soc Clin Oncol 1997 ; 16 (abstract) : 277a.
19. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TPJ.A comparison of multimodal therapy and surgery for œsophageal adenocarcinoma. N Engl J Med 1996 ; 335 : 462-7.
20. Le Prise E, Etienne PL, Meunier B et al. A randomised study of chemotherapy, radiation therapy and surgery versus surgery for localised squamous cell carcinoma of the œsopahagus.Cancer 1994 ; 73 : 1779-84.
21. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the œsophagus. N Engl J Med 1997 ; 337 : 161-7.
22. Seitz JF, Perrier H, Monges G, Giovannini M, Guvernet J. Analyse multifactorielle des facteurs pronostiques et prédictifs de réponse à la radiochimiothérapie concomitante dans les cancers épidermoïdes de l'œsophage. Intérêt de l'immunodétection de la protéine p53. Gastroenterol Clin Biol 1995 ; 19 : 465-74.
23. Ribeiro U, Finkelstein SD, Safatle-Ribeiro AV et al. p53 sequence analysis predicts treatment response and outcome of patients with œsophageal carcinoma. Cancer 1998 ; 83 : 7-18.